Barts Cancer Institute

BCI was created in 2003, and brought together some of the most eminent cancer research teams in London. We are one of the six Institutes within the Barts and The London School of Medicine and Dentistry, Queen Mary University of London.

Under the leadership of the Director, Professor Nick Lemoine, and supported by an Executive Board of senior investigators, we have created an academic environment fitting for an internationally recognised, comprehensive cancer centre.

Barts Cancer Institute has a long tradition of pioneering research and innovation. Many surgical procedures were first discovered here as well as the use of radiotherapy to treat cancer.

By investing in and undertaking world-class research, we aim to prevent cancer and develop better diagnostic techniques and treatments. This will ultimately increase patient survival and enhance the quality of life for those with long-term disease.

A wide range of research is currently underway and includes:

• Therapeutic and diagnostic target identification and validation in both haematological and solid malignancies
• Clinical trials exploring new therapies
• The development of novel molecular approaches for diagnosis
• Classification and treatment of human cancers
• Investigations into the regulation of tumour spread and host anti-tumour responses

We are recognised as one of the leading Cancer Research Institutions in the UK and are a Cancer Research UK Centre of Excellence - one of only 17 in the country.